Workflow
health care
icon
Search documents
Colgate-Palmolive (CL) Remains Overweight as JPMorgan Sees Headwinds Easing in 2026
Yahoo Finance· 2026-01-06 02:58
Group 1 - Colgate-Palmolive Company (NYSE:CL) is recognized as one of the "Dividend Kings," having increased its dividends for 63 consecutive years, which provides stability in an uncertain economy [3] - The company is focusing on everyday essentials, aiming to protect its market position through increased investment in research and innovation, enhanced marketing for core brands, and quicker responses to changing consumer preferences [3] - JPMorgan has raised its price target for Colgate-Palmolive to $88 from $87, maintaining an Overweight rating, with expectations of improved results as headwinds from 2025 are expected to ease [2] Group 2 - Colgate-Palmolive is managing higher raw material costs by implementing price increases, tighter revenue management, and improving operational efficiency [4] - The company has potential upside from its pet nutrition business, Hill's, which could benefit from the sustained demand for pet products following a surge in pet adoption during the pandemic [4] - The outlook for beverages, household, and personal care sectors remains challenging, but there is optimism for consumption and margins due to lower tariffs and favorable currency movements for multinational companies [2]
Procter & Gamble Company Stock: Analyst Estimates & Ratings
Yahoo Finance· 2025-11-05 18:30
Company Overview - Procter & Gamble Company (PG) is a global leader in consumer goods, founded in 1837 and headquartered in Cincinnati, Ohio, with a market cap of approximately $343.9 billion [1] Stock Performance - PG shares have underperformed the broader market over the past 52 weeks, declining 10.9%, while the S&P 500 Index has gained 18.5% [2] - Year-to-date, PG is down 12.2%, compared to a 15.1% rise in the S&P 500 [2] - PG has also lagged behind the Consumer Staples Select Sector SPDR Fund (XLP), which saw a 5.5% dip over the past 52 weeks and a 3.3% decline year-to-date [3] Financial Performance - The company reported muted net sales growth due to a challenging consumer and geopolitical environment, with rising input and commodity costs, tariff concerns, and weak consumer spending impacting future growth sentiment [4] Earnings Expectations - For the fiscal year ending June 2026, analysts expect PG's EPS to grow 2.6% year-over-year to $7.01, with a promising earnings surprise history [5] - Among 25 analysts covering PG, the consensus rating is a "Moderate Buy," consisting of 11 "Strong Buy" ratings, four "Moderate Buys," and 10 "Holds" [5] Analyst Ratings and Price Targets - UBS reiterated its "Buy" rating on PG with a price target of $176, citing strong quarterly earnings and greater earnings flexibility compared to peers [6] - The mean price target of $169.77 suggests a potential upside of 15.4%, while the highest price target of $181 implies a potential upside of 23% from the current price [6]
Jim Cramer Calls Procter & Gamble “The Best of the Best”
Yahoo Finance· 2025-10-28 16:02
Group 1 - Procter & Gamble (NYSE: PG) is highlighted as a top investment opportunity, particularly due to its strong performance in a challenging market environment [1] - The company reported a robust quarter, with CFO Andre Schulten providing insights into its resilient performance during the earnings call [1] - Procter & Gamble is recognized as a leading consumer packaged goods company, producing a wide range of branded products including personal care, health care, grooming, home care, and baby and family products [2] Group 2 - There is a comparison made between Procter & Gamble and certain AI stocks, suggesting that while PG is a solid investment, some AI stocks may offer greater upside potential and less downside risk [3]
Jim Cramer on Procter & Gamble: “You’ll Want to Own the Stock Ahead of Time”
Yahoo Finance· 2025-10-22 09:20
Group 1 - Procter & Gamble (NYSE:PG) is highlighted in Jim Cramer's recent game plan, with a positive outlook as the stock is believed to have bottomed out recently [1] - Cramer emphasizes the importance of Procter & Gamble's conference calls, noting their clarity and effectiveness in explaining company performance, suggesting that the upcoming call will be particularly informative [1] - Cramer previously excluded Procter & Gamble and Johnson & Johnson from his recommendations, indicating that while both are strong companies, their stock prices are currently too high [2] Group 2 - The company operates in various consumer goods sectors, including beauty, grooming, health care, fabric and home care, and baby, feminine, and family care categories [2] - There is a belief that certain AI stocks may present greater investment potential compared to Procter & Gamble, suggesting a shift in focus for investors seeking undervalued opportunities [2]